B2PRESS Eye Drop is a prescription medication used to treat glaucoma by lowering elevated eye pressure. It combines Brinzolamide and Brimonidine, which work together to reduce the production of aqueous humor and increase its outflow, effectively lowering intraocular pressure (IOP).
Brinzolamide is a carbonic anhydrase inhibitor that reduces the production of aqueous humor in the eye, which helps lower IOP.
Brimonidine is an alpha-2 adrenergic agonist that decreases IOP by both reducing the production of aqueous humor and increasing its outflow.
Together, these medications provide a dual mechanism of action to help control IOP more effectively.
B2PRESS offers effective dual action for lowering intraocular pressure (IOP) in glaucoma and ocular hypertension. Brinzolamide reduces aqueous humor production, while Brimonidine both reduces its production and increases outflow, providing enhanced IOP control. This combination helps prevent optic nerve damage, improves treatment adherence, and offers a convenient, single-dose solution for managing eye pressure.
